搜索筛选:
搜索耗时2.1379秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者:Tong Wu,Xuan Wu,Hong-Yang Wang,
来源:癌症 年份:2019
肿瘤免疫微环境与肿瘤的发生、预后和免疫治疗反应密切相关。不同类型肿瘤的免疫图谱、浸润免疫细胞数量和肿瘤中淋巴细胞的定位各不相同。癌症的免疫环境是由肿瘤浸润淋巴细...
Resected lung adenocarcinoma with micropapillary pattern displays higher positive rates of ALK expre
[会议论文] 作者:Cuicui Zhang,Shaomei Li,Zhen He,Xuan Wu,Qiming Wang,
来源:2019中国肿瘤学大会 年份:2019
...
Next-generation sequencing identified a novel WDPCP-ALK fusion sensitive to crizotinib in lung adeno
[会议论文] 作者:Xuan Wu,Zhen He,Zhe Zhang,Hongyong Fu,Qiming Wang,
来源:2019中国肿瘤学大会 年份:2019
Objective Lung cancer is the leading cause of cancer-related deaths worldwide.Over 85%of lung cancers are classified as non-small cell lung cancer(NSCLC)....
Benefits of etoposide maintenance therapy for patients with extensive SCLC who responded to first-li
[会议论文] 作者:Cuicui Zhang,Zhen He,Shaomei Li,Xuan Wu,Qiming Wang,
来源:2019中国肿瘤学大会 年份:2019
Objective The current study aims to evaluate the efficacy and safety of etoposide capsules of different doses as maintenance therapy in extensive SCLC patients responded to first line EP/EC treatment....
Sequential therapy of radiotherapy and anlotinib identified significant efficacy and safety in a pat
[会议论文] 作者:Xuan Wu,Zhen He,Shuxiang Ma,Zhe Zhang,Cuicui Zhang,Shuai Wang,Sheng Yu,Qiming Wang,
来源:2019中国肿瘤学大会 年份:2019
Objective In recent years,patients with lung adenocarcinoma have benefited significantly from tyrosine kinase inhibitors(TKIs),but not for lung squamous cell carcinoma....
相关搜索: